Stock Events

Stock Events

Mainz Biomed N.V. 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4TO.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
EXACT Sciences
EXAS
Mkt Cap20.03B
Exact Sciences Corp. offers Cologuard, a non-invasive stool DNA screening test for colorectal cancer, directly competing with Mainz Biomed's colorectal cancer detection technologies.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health, Inc. provides liquid biopsy tests that detect cancer and cancer treatment targets, competing in the broader cancer diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap525.3M
Fulgent Genetics, Inc. provides comprehensive genetic testing solutions for various diseases, including cancer, competing in the genetic testing market.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen N.V. offers sample and assay technologies for molecular diagnostics, including cancer, competing in the molecular diagnostics market.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences of California, Inc. offers sequencing systems that could be used in cancer research and diagnostics, indirectly competing in the genomics space.
Illumina
ILMN
Mkt Cap19.48B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, which are crucial in cancer research and diagnostics, making it a competitor in the genomics field.
TG Therapeutics
TGTX
Mkt Cap5.35B
TG Therapeutics, Inc. focuses on developing treatments for B-cell malignancies and autoimmune diseases, competing in the broader oncology and biopharmaceutical market.
Adaptive Biotechnologies
ADPT
Mkt Cap2.28B
Adaptive Biotechnologies Corp. offers clonoSEQ, a diagnostic test for detecting minimal residual disease in blood cancers, competing in the cancer diagnostics and monitoring market.

About

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Show more...
CEO
Mr. Guido Baechler
Employees
19
Country
United States
ISIN
NL0015000LC2

Listings

MU
DE
4TO.MU
XNAS
US
MYNZ
F
DE
4TO.F
BOATS
BOATS
MYNZ.BOATS

0 Comments

Share your thoughts

FAQ

What is Mainz Biomed N.V. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mainz Biomed N.V. stocks are traded under the ticker 4TO.MU.
How many employees does Mainz Biomed N.V. have?▼
As of April 11, 2026, the company has 19 employees.
In which sector is Mainz Biomed N.V. located?▼
Mainz Biomed N.V. operates in the Health & Wellness sector.
When did Mainz Biomed N.V. complete a stock split?▼
Mainz Biomed N.V. has not had any recent stock splits.
Where is Mainz Biomed N.V. headquartered?▼
Mainz Biomed N.V. is headquartered in Mainz, United States.